Trial intelligence / Profile preview

VSE Study in Out-of-hospital Cardiac Arrest

NCT03317197Phase 4Unknown

Sponsor
Korea University Guro Hospital
Start
Jan 2018
Primary completion
Aug 2020
Modality
Peptides, Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of vasopressin, methylprednisolone in cardiac arrest (SCA), sponsored by Korea University Guro Hospital. Status: unknown.

02

Drugs

vasopressinmethylprednisolone
03

Conditions

cardiac arrest (SCA)

Beyond the preview

Go deeper on NCT03317197.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03317197.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call